🇰🇷 Celltrion

30-day score trend

📊 Quant score trend

Last 30d quant score (PER/PBR/ROE/debt/margin/growth sector percentile)

PER 29.5 / PBR 2.53 / ROE 5.9% / 부채비율 29% / 이익률 28.1% / 매출성장 +17.0% / 이익성장 +146.2%

Not a buy or sell signal. Informational only.

📊 Latest earnings — 2026-06-30

Informational — not a buy signal. Source: DART

🕸️ Metrics radar

Informational — 5 axes are 0-100 percentile, compared to sector average

Market regime — 🇰🇷 KR (Korea)

BULL "이번 주 +10.8%, 추세는 살아 있습니다. 분위기는 들떠 있어요."

📈 7-day price

📋 Recent filings (DART)

• 08-24 투자판단관련주요경영사항 (CTP51(키트루다 바이오시밀러) 한국 품목허가 신청)
• 08-21 임원ㆍ주요주주특정증권등소유상황보고서
• 08-14 반기보고서 (2026.06)

Source: DART (Korean electronic disclosure). Reference only.

📰 Recent news

• 인천 송도 바이오기업 주가 희비...삼성바이오·셀트리온↑ SK바이오↓

  08-13 · Naver

• 셀트리온 주가, 8월 10일 장중 200,000원 0.35% 상승

  08-10 · Naver

• 올 상반기 제약바이오사, 2조6000억원 조달

  08-10 · Naver

Source: Naver. Not Tradory's opinion.

🔎 Compare info

Click a button to see database-backed metrics. Informational only, not buy or sell signals.

ⓘ This compares public financial and market data. Not a buy or sell opinion.